novo nordisk fda semaglutide wins approval for higher-dose Ozempic for adults with type 2 diabetes FDA approves Ozempic to reduce

Thighs: use the middle third of the front of each thigh

Many people at stable maintenance doses report minimal or no side effects after the initial adjustment period

Saxenda, Victoza, Wegovy, and Ozempic are FDA-approved brand medications exclusively distributed by Novo Nordisk

Government of Canada

This schedule is convenient and easier to manage compared to medications requiring daily dosing

Severe hypoglycemia is rare in patients with obesity and T2D and is usually related to causal factors such as: Overinsulinization Underfeeding Unplanned strenuous physical activity Excessive alcohol Incorrect dose of insulin or oral agents taken by patient